Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Adamas Pharmaceuticals, Inc. (ADMS)

« Back to company index

ADMS Chatter Timeline

Stock Ticker for ADMS

Most Active Tweeters for ADMS

UserTweets
@Gambiste1 4
@AmericanBanking 4
@Tickeron 3
@macondailynews 3
@TickerReport 3

Recent Tweets for ADMS

dakotafinancial @dakotafinancial
Northland Securities Analysts Give Adamas Pharmaceuticals $ADMS a $15.00 Price Target https://t.co/smZdfdfMLj
September 15th 2019, 11:09pm
WeekHerald @WeekHerald
Adamas Pharmaceuticals $ADMS Given a $15.00 Price Target by Northland Securities Analysts https://t.co/CqJo3a04zT
September 15th 2019, 11:09pm
ThisLincolnian @ThisLincolnian
Adamas Pharmaceuticals $ADMS PT Set at $15.00 by Northland Securities https://t.co/PiiJITpAM9
September 15th 2019, 11:09pm
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals $ADMS PT Set at $15.00 by Northland Securities https://t.co/P7mOwETzeN #stocks
September 15th 2019, 10:09pm
macondailynews @macondailynews
Adamas Pharmaceuticals $ADMS PT Set at $15.00 by Northland Securities https://t.co/9OWB4wbkdz
September 15th 2019, 10:09pm
stocknewstimes @stocknewstimes
Adamas Pharmaceuticals $ADMS PT Set at $15.00 by Northland Securities https://t.co/9JZjjencCG
September 15th 2019, 10:09pm
TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals $ADMS PT Set at $15.00 by Northland Securities https://t.co/1hHqIvofIq
September 15th 2019, 10:09pm
TickerReport @TickerReport
Brokers Set Expectations for Adamas Pharmaceuticals Inc’s FY2019 Earnings $ADMS https://t.co/kfIjdXB6EX
September 15th 2019, 1:09am
Tickeron @Tickeron
$ADMS's price moved above its 50-day Moving Average on September 11, 2019. View odds for this and other indicators:… https://t.co/Ox1vqXfE5Z
September 14th 2019, 7:09am
macondailynews @macondailynews
Adamas Pharmaceuticals $ADMS Stock Price Up 6.3% https://t.co/fG83yUyzGK
September 14th 2019, 1:09am
confcalltran @confcalltran
Adamas Pharmaceuticals Inc director was just granted 40,000 options https://t.co/7zOB1Rxh9c $ADMS
September 13th 2019, 5:09pm
InsiderAlertsIA @InsiderAlertsIA
$ADMS: New Insider Filing on Director DAVID L MAHONEY: https://t.co/wBWTSU96rA
September 13th 2019, 5:09pm
Gambiste1 @Gambiste1
RT @BioTuesdays: Adamas Pharma names Neil McFarlane as CEO $ADMS https://t.co/eSuW88SwJJ
September 13th 2019, 3:09pm
BioTuesdays @BioTuesdays
Adamas Pharma names Neil McFarlane as CEO $ADMS https://t.co/eSuW88SwJJ
September 13th 2019, 1:09pm
marketexclusive @marketexclusive
$ADMS ADAMAS PHARMACEUTICALS, INC. (NASDAQ:ADMS) Files An 8-K Departure of Directors or Certain Officers; Election… https://t.co/G5c53kvhQV
September 13th 2019, 1:09pm
Gambiste1 @Gambiste1
RT @MarketCurrents: $ADMS - New chief at Adamas Pharma https://t.co/CyLqMEM1fe
September 13th 2019, 12:09pm
Gambiste1 @Gambiste1
RT @MarketCurrents: $ADMS - New CEO at Adamas Pharma https://t.co/IYav4eE0ce
September 13th 2019, 12:09pm
Gambiste1 @Gambiste1
RT @HottestStockNow: $ADMS Makes Strategic Move #Adamas https://t.co/WqFUFocxxp
September 13th 2019, 12:09pm
AlertTrade @AlertTrade
RT @Briefingcom: $ADMS: Adamas Pharmaceuticals announced that Neil McFarlane has been named Chief Executive Officer and appointed to... htt…
September 13th 2019, 9:09am
Briefingcom @Briefingcom
$ADMS: Adamas Pharmaceuticals announced that Neil McFarlane has been named Chief Executive Officer and appointed to… https://t.co/tiaD5X0qu8
September 13th 2019, 9:09am
InsiderBiotech @InsiderBiotech
$ADMS Adamas Pharmaceuticals appoints Neil McFarlane as CEO and the member of Board of Directors, effective Septem… https://t.co/duvAMyIPVo
September 13th 2019, 9:09am
Stock_News_Now @Stock_News_Now
$ADMS: New SEC Filing for ADMS: Form 8-K (No. 0001328143-19-000038): https://t.co/ITVwseR7xG
September 13th 2019, 8:09am
newswithvalue @newswithvalue
$ADMS: New chief at Adamas Pharma: https://t.co/IJ9bjFN9ZZ
September 13th 2019, 8:09am
MarketCurrents @MarketCurrents
$ADMS - New chief at Adamas Pharma https://t.co/CyLqMEM1fe
September 13th 2019, 8:09am
newswithvalue @newswithvalue
$ADMS: New CEO at Adamas Pharma: https://t.co/ZsoQfiklDN
September 13th 2019, 8:09am
HottestStockNow @HottestStockNow
$ADMS Makes Strategic Move #Adamas https://t.co/WqFUFocxxp
September 13th 2019, 8:09am
StockTexts @StockTexts
$ADMS Adamas Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/8oW8iOcJtF
September 13th 2019, 7:09am
MarketCurrents @MarketCurrents
$ADMS - New CEO at Adamas Pharma https://t.co/IYav4eE0ce
September 13th 2019, 7:09am
confcalltran @confcalltran
Departure of Directors or Certain https://t.co/0QLWAct80h $ADMS
September 13th 2019, 7:09am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc Expected to Post FY2019 Earnings of -$3.01 Per Share $ADMS https://t.co/xVTALrXjWx #stocks
September 13th 2019, 6:09am
RatingsNetwork @RatingsNetwork
Cantor Fitzgerald Sets Adamas Pharmaceuticals FY2019 Earnings Estimates at ($3.01) EPS. https://t.co/nKI7E3sB8u $ADMS #ADMS
September 13th 2019, 6:09am
Tickeron @Tickeron
$ADMS in Downtrend: 50-day Moving Average moved below 200-day Moving Average on July 2, 2018. View odds for this an… https://t.co/K4neFSb5Rh
September 13th 2019, 4:09am
macondailynews @macondailynews
Cantor Fitzgerald Begins Coverage on Adamas Pharmaceuticals $ADMS https://t.co/C2Ff3Lm9qz
September 13th 2019, 4:09am
stocknewstimes @stocknewstimes
Cantor Fitzgerald Begins Coverage on Adamas Pharmaceuticals $ADMS https://t.co/iLR3uzboBt
September 13th 2019, 4:09am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/uSEbJ1yKuD #stocks
September 12th 2019, 10:09am
OlympiaReport @OlympiaReport
Cantor Fitzgerald Begins Coverage on Adamas Pharmaceuticals $ADMS https://t.co/PBTdjsjXWV
September 12th 2019, 10:09am
ConsumerFeed @ConsumerFeed
Adamas Pharmaceuticals $ADMS Shares Up 6.3% https://t.co/BovmK37gdR
September 12th 2019, 12:09am
TickerReport @TickerReport
Adamas Pharmaceuticals $ADMS Coverage Initiated at Cantor Fitzgerald https://t.co/BHMB7ezzdd
September 11th 2019, 2:09am
StockNewsWires @StockNewsWires
$ADMS $WCG: Morgan Stanley sees 23% upside in Galapagos in premarket …: https://t.co/jTC9f03u5K
September 9th 2019, 9:09am
TickerReport @TickerReport
Analysts’ New Coverage for September, 9th $ADMS, ALLVF, ASPU, ATUS, CFB, CVET, ELAN, IDXX, KMPR, KRUS https://t.co/F9QQ2qqz0R
September 9th 2019, 8:09am
AmericanBanking @AmericanBanking
Cantor Fitzgerald Begins Coverage on Adamas Pharmaceuticals $ADMS https://t.co/Zo4ZYfeepc #stocks
September 9th 2019, 8:09am
Tickeron @Tickeron
$ADMS in Downtrend: 50-day Moving Average broke below 200-day Moving Average on July 2, 2018. View odds for this an… https://t.co/gDa3zjTJwm
September 9th 2019, 3:09am
TickerReport @TickerReport
Adamas Pharmaceuticals $ADMS Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS https://t.co/ZfyljiGY1I
August 11th 2019, 10:08am
ZolmaxNews @ZolmaxNews
Adamas Pharmaceuticals $ADMS Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPS https://t.co/6LYO5U1BlR
August 11th 2019, 10:08am
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals $ADMS Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS https://t.co/RtNbZa2Ljb
August 11th 2019, 10:08am
ChartMill @ChartMill
$ADMS has a bad technical rating, but it does show a decent setup pattern. https://t.co/bDgiaZAttg https://t.co/CiEefaCojB
August 10th 2019, 10:08pm
dakotafinancial @dakotafinancial
Adamas Pharmaceuticals $ADMS Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS https://t.co/CmsYz4p0Bu
August 10th 2019, 5:08pm
macondailynews @macondailynews
Adamas Pharmaceuticals $ADMS Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/7juARxMYGJ
August 10th 2019, 5:08pm
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals $ADMS Announces Quarterly Earnings Results https://t.co/wRXGZ5tM28
August 10th 2019, 5:08pm
TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals $ADMS Announces Quarterly Earnings Results https://t.co/XIgViR8LYp
August 10th 2019, 5:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.